Cargando…
Intrahepatic Cholangiocarcinoma: State of the Art of FGFR Inhibitors
OBJECTIVE: Intrahepatic cholangiocarcinoma (iCCA), the second most common type of primary liver tumor, has an increasing incidence in the past few decades. iCCA is highly malignant, with a 5-year survival rate of approximately 5-10%. Surgical resection is usually the prescribed treatment for patient...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482710/ https://www.ncbi.nlm.nih.gov/pubmed/33618536 http://dx.doi.org/10.1177/1073274821989314 |